BATS BZX Real-Time Price
As of 10:53am ET
| +0.09 / +2.28%|
The 2 analysts offering 12-month price forecasts for Tetraphase Pharmaceuticals Inc have a median target of 9.00, with a high estimate of 14.00 and a low estimate of 4.00. The median estimate represents a +122.77% increase from the last price of 4.04.
The current consensus among 7 polled investment analysts is to Hold stock in Tetraphase Pharmaceuticals Inc. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.